SEC Form 4 · accession 0001176488-18-000001

Sanara MedTech Inc. · SMTI

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Director · 10% Owner

Period of report

Feb 19, 2018

Accepted (ET)

May 9, 2018 · 8:04 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000714256

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1,F4	Feb 19, 2018	J	11,325,678	$0.07	A	11,475,678	I	By Trust
Common Stock^F2,F4	Feb 19, 2018	J	10,799,586	$0.07	A	22,125,264	I	By Trust
Common Stock^F3,F4	Feb 27, 2018	J	19,817,165	$0.07	A	42,092,429	I	By Trust

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Series C Preferred Stock^F2,F4	—	Feb 19, 2018	J	9,745	D	Apr 11, 2016	—	Common Stock	10,799,586	16,535	I
Series C Preferred Stock^F3,F4	—	Feb 27, 2018	J	16,535	D	Jan 24, 2014	—	Common Stock	19,817,165	0	I

F1On February 19, 2018, the Solomon Oden Howell Revocable Trust converted all principal and interest under that certain promissory note, dated as of June 15, 2015, in the principal amount of $600,000, into 11,325,678 shares of the Company's Common Stock.
F2On February 19, 2018, the Solomon Oden Howell Revocable Trust converted 9,745 shares of the Company's Series C Convertible Preferred Stock, together with all accrued but unpaid dividends thereon, into a total of 10,799,586 shares of the Company's Common Stock.
F3On February 27, 2018, the Solomon Oden Howell Revocable Trust converted 16,535 shares of the Company's Series C Convertible Preferred Stock, together with all accrued but unpaid dividends thereon, into a total of 19,817,165 shares of the Company's Common Stock.
F4The reporting person is the trustee of the Solomon Oden Howell Revocable Trust.